FORMELA JEAN FRANCOIS 4
4 · Intellia Therapeutics, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
FORMELA JEAN FRANCOIS
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-14+7,688→ 7,688 totalExercise: $38.49Exp: 2032-06-13→ Common Stock (7,688 underlying) - Award
Common Stock
2022-06-14+5,197→ 7,291 total
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on June 14, 2022 with respect to 7,688 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
- [F3]The reporting person is a member of Atlas Venture Associates IX, LLC ("AVA IX LLC") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to Atlas Venture Advisors, L.P. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.